Stanley L Hazen
Stanley L Hazen
Verified email at ccf.org
Title
Cited by
Cited by
Year
Heart disease and stroke statistics—2015 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
circulation 131 (4), e29-e322, 2015
49649*2015
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Z Wang, E Klipfell, BJ Bennett, R Koeth, BS Levison, B DuGar, ...
Nature 472 (7341), 57-63, 2011
35552011
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis
RA Koeth, Z Wang, BS Levison, JA Buffa, E Org, BT Sheehy, EB Britt, X Fu, ...
Nature medicine 19 (5), 576-585, 2013
28622013
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
WHW Tang, Z Wang, BS Levison, RA Koeth, EB Britt, X Fu, Y Wu, ...
New England Journal of Medicine 368 (17), 1575-1584, 2013
21172013
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
H Schunkert, IR König, S Kathiresan, MP Reilly, TL Assimes, H Holm, ...
Nature genetics 43 (4), 333-338, 2011
17672011
A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease
M Nikpay, A Goel, HH Won, LM Hall, C Willenborg, S Kanoni, D Saleheen, ...
Nature genetics 47 (10), 1121, 2015
13712015
Large-scale association analysis identifies new risk loci for coronary artery disease
P Deloukas, S Kanoni, C Willenborg, M Farrall, TL Assimes, ...
Nature genetics 45 (1), 25-33, 2013
13572013
Prognostic value of myeloperoxidase in patients with chest pain
ML Brennan, MS Penn, F Van Lente, V Nambi, MH Shishehbor, RJ Aviles, ...
New England Journal of Medicine 349 (17), 1595-1604, 2003
13252003
Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
M Febbraio, EA Podrez, JD Smith, DP Hajjar, SL Hazen, HF Hoff, ...
The Journal of clinical investigation 105 (8), 1049-1056, 2000
11632000
Association between myeloperoxidase levels and risk of coronary artery disease
R Zhang, ML Brennan, X Fu, RJ Aviles, GL Pearce, MS Penn, EJ Topol, ...
Jama 286 (17), 2136-2142, 2001
11042001
3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.
SL Hazen, JW Heinecke
The Journal of clinical investigation 99 (9), 2075-2081, 1997
9311997
Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis
SJ Nicholls, EM Tuzcu, I Sipahi, AW Grasso, P Schoenhagen, T Hu, ...
Jama 297 (5), 499-508, 2007
8872007
Apolipoprotein AI is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease
L Zheng, B Nukuna, ML Brennan, M Sun, M Goormastic, M Settle, ...
The Journal of clinical investigation 114 (4), 529-541, 2004
8142004
Myeloperoxidase and cardiovascular disease
SJ Nicholls, SL Hazen
Arteriosclerosis, thrombosis, and vascular biology 25 (6), 1102-1111, 2005
7992005
Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk
W Zhu, JC Gregory, E Org, JA Buffa, N Gupta, Z Wang, L Li, X Fu, Y Wu, ...
Cell 165 (1), 111-124, 2016
7792016
Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease
CR Morris, GJ Kato, M Poljakovic, X Wang, WC Blackwelder, V Sachdev, ...
Jama 294 (1), 81-90, 2005
7232005
Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis
Z Wang, AB Roberts, JA Buffa, BS Levison, W Zhu, E Org, X Gu, Y Huang, ...
Cell 163 (7), 1585-1595, 2015
6722015
Myeloperoxidase-generated oxidants and atherosclerosis
EA Podrez, HM Abu-Soud, SL Hazen
Free Radical Biology and Medicine 28 (12), 1717-1725, 2000
6672000
Protein carbamylation links inflammation, smoking, uremia and atherogenesis
Z Wang, SJ Nicholls, ER Rodriguez, O Kummu, S Hörkkö, J Barnard, ...
Nature medicine 13 (10), 1176-1184, 2007
6352007
Gut Microbiota-Dependent Trimethylamine N-Oxide (TMAO) Pathway Contributes to Both Development of Renal Insufficiency and Mortality Risk in Chronic Kidney …
WHW Tang, Z Wang, DJ Kennedy, Y Wu, JA Buffa, B Agatisa-Boyle, XS Li, ...
Circulation research 116 (3), 448-455, 2015
6062015
The system can't perform the operation now. Try again later.
Articles 1–20